InnovAge Holding Corp. Direct Operating Costs
InnovAge Holding Corp. (INNV) reported Direct Operating Costs of $312.10 million for the 12-month period ending 2026-06-30, per its 10-K filed 2026-09-09.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:DirectOperatingCosts · last filed 2026-09-09
- InnovAge Holding Corp. direct operating costs for the quarter ending 2026-06-30 was $83.65M, a 16.25% increase year-over-year.
- InnovAge Holding Corp. direct operating costs for the quarter ending 2026-03-31 was $77.68M, a 11.77% increase year-over-year.
- InnovAge Holding Corp. direct operating costs for the quarter ending 2025-12-31 was $74.88M, a 16.89% increase year-over-year.
- InnovAge Holding Corp. direct operating costs for the quarter ending 2025-09-30 was $75.89M, a 19.72% increase year-over-year.
- InnovAge Holding Corp. direct operating costs for fiscal 2026 was $312.10M, a 16.06% increase from fiscal 2025.
- InnovAge Holding Corp. direct operating costs for fiscal 2025 was $268.91M, a 17.54% increase from fiscal 2024.
- InnovAge Holding Corp. direct operating costs for fiscal 2024 was $228.78M, a 7.78% increase from fiscal 2023.
- InnovAge Holding Corp. direct operating costs for fiscal 2023 was $212.27M, a 17.78% increase from fiscal 2022.
| Period end | Direct Operating Costs 3 month | Direct Operating Costs 6 month | Direct Operating Costs 9 month | Direct Operating Costs 12 month |
|---|---|---|---|---|
| 2026-06-30 | $83.65M derived: 10-K 12 month − 10-Q 9 month · filed 2026-09-09 | $161.33M derived: sum of 2 quarters · filed 2026-09-09 | $236.21M derived: sum of 3 quarters · filed 2026-09-09 | $312.10M 10-K · filed 2026-09-09 |
| 2026-03-31 | $77.68M 10-Q · filed 2026-05-08 | $152.56M derived: sum of 2 quarters · filed 2026-05-08 | $228.45M 10-Q · filed 2026-05-08 | $300.41M derived: sum of 4 quarters · filed 2026-09-09 |
| 2025-12-31 | $74.88M 10-Q · filed 2026-02-03 | $150.77M 10-Q · filed 2026-02-03 | $222.73M derived: sum of 3 quarters · filed 2026-09-09 | $292.23M derived: sum of 4 quarters · filed 2026-09-09 |
| 2025-09-30 | $75.89M 10-Q · filed 2025-11-04 | $147.85M derived: sum of 2 quarters · filed 2026-09-09 | $217.35M derived: sum of 3 quarters · filed 2026-09-09 | $281.41M derived: sum of 4 quarters · filed 2026-09-09 |
| 2025-06-30 | $71.96M derived: 10-K 12 month − 10-Q 9 month · filed 2026-09-09 | $141.46M derived: sum of 2 quarters · filed 2026-09-09 | $205.52M derived: sum of 3 quarters · filed 2026-09-09 | $268.91M 10-K · filed 2026-09-09 |
| 2025-03-31 | $69.50M 10-Q · filed 2026-05-08 | $133.56M derived: sum of 2 quarters · filed 2026-05-08 | $196.95M 10-Q · filed 2026-05-08 | $257.08M derived: sum of 4 quarters · filed 2026-05-08 |
| 2024-12-31 | $64.06M 10-Q · filed 2026-02-03 | $127.45M 10-Q · filed 2026-02-03 | $187.58M derived: sum of 3 quarters · filed 2026-02-03 | $246.66M derived: sum of 4 quarters · filed 2026-02-03 |
| 2024-09-30 | $63.39M 10-Q · filed 2025-11-04 | $123.52M derived: sum of 2 quarters · filed 2025-11-04 | $182.60M derived: sum of 3 quarters · filed 2025-11-04 | $236.92M derived: sum of 4 quarters · filed 2025-11-04 |
| 2024-06-30 | $60.13M derived: 10-K 12 month − 10-Q 9 month · filed 2025-09-09 | $119.21M derived: sum of 2 quarters · filed 2025-09-09 | $173.53M derived: sum of 3 quarters · filed 2025-09-09 | $228.78M 10-K · filed 2025-09-09 |
| 2024-03-31 | $59.08M 10-Q · filed 2025-05-06 | $113.40M derived: sum of 2 quarters · filed 2025-05-06 | $168.65M 10-Q · filed 2025-05-06 | $222.04M derived: sum of 4 quarters · filed 2025-05-06 |
| 2023-12-31 | $54.32M 10-Q · filed 2025-02-04 | $109.57M 10-Q · filed 2025-02-04 | $162.96M derived: sum of 3 quarters · filed 2025-02-04 | $216.91M derived: sum of 4 quarters · filed 2025-02-04 |
| 2023-09-30 | $55.25M 10-Q · filed 2024-11-05 | $108.64M derived: sum of 2 quarters · filed 2024-11-05 | $162.59M derived: sum of 3 quarters · filed 2024-11-05 | $213.97M derived: sum of 4 quarters · filed 2024-11-05 |
| 2023-06-30 | $53.39M derived: 10-K 12 month − 10-Q 9 month · filed 2024-09-10 | $107.34M derived: sum of 2 quarters · filed 2024-09-10 | $158.72M derived: sum of 3 quarters · filed 2024-09-10 | $212.27M 10-K · filed 2024-09-10 |
| 2023-03-31 | $53.95M 10-Q · filed 2024-05-07 | $105.33M derived: sum of 2 quarters · filed 2024-05-07 | $158.88M 10-Q · filed 2024-05-07 | $209.36M derived: sum of 4 quarters · filed 2024-05-07 |
| 2022-12-31 | $51.38M 10-Q · filed 2024-02-06 | $104.93M 10-Q · filed 2024-02-06 | $155.41M derived: sum of 3 quarters · filed 2024-02-06 | $201.52M derived: sum of 4 quarters · filed 2024-02-06 |
| 2022-09-30 | $53.56M 10-Q · filed 2023-11-07 | $104.04M derived: sum of 2 quarters · filed 2023-11-07 | $150.14M derived: sum of 3 quarters · filed 2023-11-07 | $193.05M derived: sum of 4 quarters · filed 2023-11-07 |
| 2022-06-30 | $50.48M derived: 10-K 12 month − 10-Q 9 month · filed 2023-09-12 | $96.58M derived: sum of 2 quarters · filed 2023-09-12 | $139.50M derived: sum of 3 quarters · filed 2023-09-12 | $180.22M 10-K · filed 2023-09-12 |
| 2022-03-31 | $46.10M 10-Q · filed 2023-05-09 | $89.01M derived: sum of 2 quarters · filed 2023-05-09 | $129.74M 10-Q · filed 2023-05-09 | $168.22M derived: sum of 4 quarters · filed 2023-05-09 |
| 2021-12-31 | $42.91M 10-Q · filed 2023-02-07 | $83.64M 10-Q · filed 2023-02-07 | $122.12M derived: sum of 3 quarters · filed 2023-02-07 | $161.69M derived: sum of 4 quarters · filed 2023-02-07 |
| 2021-09-30 | $40.73M 10-Q · filed 2022-11-08 | $79.21M derived: sum of 2 quarters · filed 2022-11-08 | $118.77M derived: sum of 3 quarters · filed 2022-11-08 | $156.85M derived: sum of 4 quarters · filed 2022-11-08 |
| 2021-06-30 | $38.48M derived: 10-K 12 month − 10-Q 9 month · filed 2022-09-13 | $78.05M derived: sum of 2 quarters · filed 2022-09-13 | $116.12M derived: sum of 3 quarters · filed 2022-09-13 | $154.40M 10-K · filed 2022-09-13 |
| 2021-03-31 | $39.56M 10-Q · filed 2022-05-10 | $77.64M derived: sum of 2 quarters · filed 2022-05-10 | $115.92M 10-Q · filed 2022-05-10 | $154.51M derived: sum of 4 quarters · filed 2022-05-10 |
| 2020-12-31 | $38.07M 10-Q · filed 2022-02-09 | $76.36M 10-Q · filed 2022-02-09 | $114.95M derived: sum of 3 quarters · filed 2022-02-09 | $154.23M derived: sum of 4 quarters · filed 2022-02-09 |
| 2020-09-30 | $38.28M 10-Q · filed 2021-11-09 | $76.87M derived: sum of 2 quarters · filed 2021-11-09 | $116.16M derived: sum of 3 quarters · filed 2021-11-09 | |
| 2020-06-30 | $38.59M derived: 10-K 12 month − 10-Q 9 month · filed 2021-09-23 | $77.88M derived: sum of 2 quarters · filed 2021-09-23 | $153.06M 10-K · filed 2021-09-23 | |
| 2020-03-31 | $39.28M 10-Q · filed 2021-05-11 | $114.47M 10-Q · filed 2021-05-11 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Omada Health, Inc. (OMDA) | United States | $1.207B | 309.08 |
| U S PHYSICAL THERAPY INC /NV (USPH) | United States | $1.251B | 32.48 |
| Pennant Group, Inc. (PNTG) | United States | $1.386B | 39.84 |
| Strata Critical Medical, Inc. (SRTA) | United States | $0.467B | 11.33 |
| DocGo Inc. (DCGO) | United States | $0.034B | -0.25 |
| VSEE HEALTH, INC. (VSEE) | United States | $0.003B | |
| Agape ATP Corp (ATPC) | $0.002B | ||
| Privia Health Group, Inc. (PRVA) | United States | $2.477B | 115.52 |
| GeneDx Holdings Corp. (WGS) | United States | $2.638B | -19.23 |
| LifeStance Health Group, Inc. (LFST) | United States | $4.510B | 80.86 |